THREAD is a singular, fully configurable decentralized clinical trial platform with services that deliver global scalability and rapid flexibility from virtual clinical trial study design to close-out – this is our UNCOMMON THREAD.
AGC Biologics is a global CDMO providing end-to-end pharmaceutical development and manufacturing services for protein-based biologics and cell and gene therapies. With seven facilities and teams of scientists across three continents, we have the resources and the available capacity you need to accelerate your race to GMP. From development, to clinical trials, to full-scale commercialization, we can help you reach your goals at any stage in the drug development and manufacturing process.
We specialize in the following modalities and substances, mammalian and microbial-based therapeutic proteins, recombinant DNA, plasmid DNA, viral vectors, Messenger RNA (mRNA) and genetically engineered cells. Our services range from Process Development, Analytical Development, cGMP Manufacturing, Quality Control and Quality Assurance and Process Validation.
Yposkesi is one of the largest Contract Development & Manufacturing Organizations (CDMO) in Europe. Dedicated to viral vector manufacturing for gene therapy, Yposkesi is a one-stop shop offering: bioprocess development (upstream and downstream processing), analytical development, small/pilot to large-scale production, cGMP manufacturing of clinical batches of lentiviral vectors and AAV (Adeno-Associated Virus) and regulatory support. Yposkesi is expanding and with a new building, will offer commercial batches production in 2023.
Through a well-defined customer needs driven approach to design, production, installation and qualification, G-CON provides a fully functional cleanroom product portfolio enabling reliable biocapacity planning on-time and within-budget.
ProPharma Group is the global, independent, single-source provider of regulatory and compliance consulting, clinical research services, pharmacovigilance, and medical information serving pharmaceutical, biotechnology, and medical device companies. Founded in 2001, ProPharma Group has more than 2500 colleagues worldwide providing a comprehensive portfolio of regulatory, clinical and compliance solutions to help solve complex challenges in a dynamic regulatory environment. With the mission to improve the health and safety of patients, ProPharma Group is focused on delivering the highest quality of services throughout the full product lifecycle. For more information, please visit